Discover the full record of transactions filed by Otsuka Pharmaceutical Co., Ltd., 股东. Director active across 1 company, notably 栄研化学株式会社. Cumulatively, 2 filings have been published. History available since 23 December 2022. The latest transaction was disclosed on 23 December 2022 (Holding update). Regulator: EDINET (Japan FSA). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Otsuka Pharmaceutical Co., Ltd. is a major shareholder and officer at 栄研化学株式会社. His role allows him to influence strategic decisions and actively participate in the governance of the company. 栄研化学株式会社 specializes in developing pharmaceutical solutions. Otsuka Pharmaceutical Co., Ltd. brings significant expertise to the company through its position.